Clinical trials
Completed Immune System Diseases trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
100 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2005 | 4 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 9 |
| 2011 | 5 |
| 2012 | 5 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 3 |
| 2016 | 7 |
| 2017 | 6 |
| 2018 | 7 |
| 2019 | 1 |
| 2020 | 5 |
| 2021 | 8 |
| 2022 | 5 |
| 2023 | 6 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 100 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kadmon, a Sanofi Company | 5 |
| National Center for Research Resources (NCRR) | 5 |
| AstraZeneca | 3 |
| Ellodi Pharmaceuticals, LP | 3 |
| Memgen, LLC | 3 |
| Pfizer | 3 |
| Yale University | 3 |
| Appalachian State University | 2 |
| Columbia University | 2 |
| Eli Lilly and Company | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Immune System Diseases | 100 |
| Autoimmune Diseases | 29 |
| Hypersensitivity | 16 |
| Hypersensitivity, Immediate | 15 |
| Communicable Diseases | 11 |
| Lupus Erythematosus, Systemic | 11 |
| Rare Diseases | 11 |
| Skin Diseases | 10 |
| Connective Tissue Diseases | 8 |
| Nervous System Diseases | 8 |
Trials
Showing 1 to 25 of 100. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.